Postoperative Nausea and Vomiting (PONV) Management Market is Expected to Record the Massive Growth, with Prominent Key Players 2023 To 2033


 During the forecast period 2023 to 2033, the Postoperative Nausea And Vomiting (PONV) Management Market is expected to grow at a value of 12.8% CAGR, according to Future Market Insights. By the year 2033, the global market for Postoperative nausea and vomiting (PONV) management is expected to rise up to a market valuation of US$ 3.9 Billion. Growth of the market can be attributed to various factors, including the increasing number of surgical procedures being performed worldwide, the rising prevalence of PONV, and the development of novel antiemetic drugs and treatment methods.

North America and Europe are currently the largest markets for PONV management, primarily due to the high prevalence of PONV in these regions and the availability of advanced healthcare facilities. However, the Asia-Pacific region is expected to experience the highest growth rate in the coming years, due to the increasing number of surgical procedures being performed in countries like China and India, as well as the growing demand for effective PONV management options in the region.

Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16883

Various companies are working towards developing new and effective drugs for PONV management, including Acacia Pharma, Eisai Co., Ltd., GlaxoSmithKline, Hoffmann-La Roche AG, and Merck & Co., Inc. These companies are also focusing on strategic collaborations and partnerships to expand their market presence and offer better treatment options to patients.

Key Takeaways from the Market Study

  • The global Postoperative nausea and vomiting (PONV) management market is expected to grow with a 12.8% CAGR during 2023 to 2033.
  • By distribution channel, hospital pharmacies are expected to hold 49% of the market share in 2023 for Postoperative nausea and vomiting (PONV) management market.
  • North America is expected to possess 47% market share for Postoperative nausea and vomiting (PONV) management market in 2023.
  • Europe Postoperative nausea and vomiting (PONV) management market size is expected to possess 43% market share in 2023.

“The PONV management market is expected to experience significant growth in the coming years, driven by increasing demand for effective treatment options and advancements in drug development.” states an FMI analyst

Competitive Landscape

Key players in the postoperative nausea and vomiting (PONV) management market are Acacia Pharma, Hoffmann-La Roche AG, Novartis AG, Ani Pharmaceuticals, Inc, Camurus AB, Sanofi S.A., Helsinn Holding S.A., Eisai Corporation, Merck and Co., GlaxoSmithKline Corporation

  • Acacia Pharma has developed a patient-controlled analgesia (PCA) system for PONV management. The PCA system delivers a combination of opioids and antiemetic medications through a patient-controlled pump. The system has been shown to be highly effective in reducing the incidence of PONV and improving patient satisfaction.
  • Roche's key antiemetic medications for PONV management is Kytril (granisetron). Kytril is a selective 5-HT3 receptor antagonist that works by blocking the action of serotonin, a neurotransmitter that is involved in the development of nausea and vomiting. The drug is administered intravenously and has been shown to be highly effective in the prevention and treatment of PONV.

Key Segments Profiled in the Postoperative Nausea and Vomiting (PONV) Management Industry Survey

Treatment Type:

  • Serotonin Antagonists
  • Steroids
  • Dopamine Antagonists
  • Neurokinin NK-1 Receptor Antagonists
  • Non-pharmacological Treatment

Distribution Channel:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies and Drug Stores

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more